Loading clinical trials...
Loading clinical trials...
A Phase II Trial of Preoperative Concurrent Chemotherapy/Radiation Therapy Plus Bevacizumab/Erlotinib in the Treatment of Localized Esophageal Cancer
Conditions
Interventions
Erlotinib
Bevacizumab
+5 more
Locations
9
United States
Florida Cancer Specialists
Fort Myers, Florida, United States
Integrated Community Oncology Network
Jacksonville, Florida, United States
Northeast Georgia Medical Center
Gainesville, Georgia, United States
Consultants in Blood Disorders and Cancer
Louisville, Kentucky, United States
Hematology Oncology Associates of Northern NJ
Morristown, New Jersey, United States
Aultman Hospital
Canton, Ohio, United States
Start Date
February 1, 2007
Primary Completion Date
September 1, 2009
Completion Date
August 1, 2011
Last Updated
March 2, 2022
NCT04674267
NCT07217704
NCT07464470
NCT07132918
NCT07367516
NCT06346080
Lead Sponsor
SCRI Development Innovations, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions